Pillstats
Rx only · Tablet, Orally Disintegrating · Oral

Amphetamine

Brands: Adzenys Xr-Odt · Amphetamine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)725
US makers2 labelers
Packages12
DEA / ScheduleCII

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.56$11.13$16.69$22.26Dec 2025Mar 2026Jul 2026
$17.696
Latest avg · Jul 22, 2026
-9%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.2K6.4K9.7K13K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.8K
Rx · 2026 Q1
181K
Units dispensed
-48%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown6SUPPLYING
Neos Therapeutics, LPunknown6SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.